Literature DB >> 33806428

From Liver Fat to Cancer: Perils of the Western Diet.

Ju Youn Kim1, Feng He2, Michael Karin1.   

Abstract

Hepatocellular carcinoma (HCC), the most common type of primary liver cancer provides the prototypical example of an obesity-related cancer. The obesity epidemic gave rise to an enormous increase in the incidence of non-alcoholic fatty liver disease (NAFLD), a condition that affects one third of American adults. In about 20% of these individuals, simple liver steatosis (hepatosteatosis) progresses to non-alcoholic steatohepatitis (NASH) characterized by chronic liver injury, inflammation, and fibrosis. In addition to liver failure, NASH greatly increases the risk of HCC. Here we discuss the metabolic processes that control the progression from NAFLD to NASH and from NASH to HCC, with a special emphasis on the role of free-non-esterified cholesterol in the process.

Entities:  

Keywords:  HCC; NAFLD; NASH; cholesterol; obesity

Year:  2021        PMID: 33806428      PMCID: PMC7961422          DOI: 10.3390/cancers13051095

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  153 in total

1.  A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver.

Authors:  H Yamashita; M Takenoshita; M Sakurai; R K Bruick; W J Henzel; W Shillinglaw; D Arnot; K Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

Review 2.  Hepatocellular Carcinoma: Etiology and Current and Future Drugs.

Authors:  Aastha Jindal; Anusha Thadi; Kunwar Shailubhai
Journal:  J Clin Exp Hepatol       Date:  2019-01-25

3.  Pathology of the liver in obese and diabetic ob/ob and db/db mice fed a standard or high-calorie diet.

Authors:  Viviane Trak-Smayra; Valérie Paradis; Julie Massart; Selim Nasser; Victor Jebara; Bernard Fromenty
Journal:  Int J Exp Pathol       Date:  2011-11-25       Impact factor: 1.925

4.  Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis.

Authors:  George N Ioannou; W Geoffrey Haigh; David Thorning; Christopher Savard
Journal:  J Lipid Res       Date:  2013-02-17       Impact factor: 5.922

Review 5.  AMP-activated protein kinase: the current landscape for drug development.

Authors:  Gregory R Steinberg; David Carling
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

6.  Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist.

Authors:  Edward E Cable; Patricia D Finn; Jeffrey W Stebbins; Jinzhao Hou; Bruce R Ito; Paul D van Poelje; David L Linemeyer; Mark D Erion
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

7.  Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected].

Authors:  Bangyan Stiles; Ying Wang; Andreas Stahl; Sara Bassilian; W Paul Lee; Yoon-Jung Kim; Robert Sherwin; Sherin Devaskar; Ralf Lesche; Mark A Magnuson; Hong Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

8.  [Serum cholesterol and cancer mortality: eleven-year prospective cohort study on more than nine thousand persons].

Authors:  W X Li
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  1993-02

9.  Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.

Authors:  Sang-Wook Yi; Se Hwa Kim; Ki Jun Han; Jee-Jeon Yi; Heechoul Ohrr
Journal:  Br J Cancer       Date:  2019-12-20       Impact factor: 7.640

10.  Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems.

Authors:  Trenton T Ross; Collin Crowley; Kenneth L Kelly; Anthony Rinaldi; David A Beebe; Matthew P Lech; Robert V Martinez; Santos Carvajal-Gonzalez; Magalie Boucher; Dinesh Hirenallur-Shanthappa; Jeffrey Morin; Alan C Opsahl; Sarah R Vargas; Kendra K Bence; Jeffrey A Pfefferkorn; William P Esler
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2020-06-09
View more
  2 in total

1.  Human Mesenchymal Stromal Cells Resolve Lipid Load in High Fat Diet-Induced Non-Alcoholic Steatohepatitis in Mice by Mitochondria Donation.

Authors:  Sandra Nickel; Madlen Christ; Sandra Schmidt; Joanna Kosacka; Hagen Kühne; Martin Roderfeld; Thomas Longerich; Lysann Tietze; Ina Bosse; Mei-Ju Hsu; Peggy Stock; Elke Roeb; Bruno Christ
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

Review 2.  Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis.

Authors:  Ting Wang; Taichi Ishikawa; Minoru Sasaki; Toshimi Chiba
Journal:  Front Med (Lausanne)       Date:  2022-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.